Todd Watanabe
Algemeen Directeur bij ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 9 M $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Keith Leonard | M | 62 | 14 jaar | |
| Bhaskar Chaudhuri | M | 69 | 8 jaar | |
| Patrick Heron | M | 53 | 8 jaar | |
| Jay Ramsinghani | M | - | 6 jaar | |
| Ciara Kennedy | M | 52 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 jaar |
| Neha Krishnamohan | F | 37 | 2 jaar | |
| Masaru Matsuda | M | 53 | 2 jaar | |
| Sue-Jean Lin | F | 65 | 3 jaar | |
| Terrie Curran | F | 55 | 4 jaar | |
| Ayisha Jeter | F | - | 4 jaar | |
| Howard Welgus | M | 72 | 8 jaar | |
| Volker Schellenberger | M | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 18 jaar |
| Ambrose Bailey | M | 60 | 9 jaar | |
| Halley Gilbert | F | 54 | 4 jaar | |
| Maria Hilado | F | 59 | 9 jaar | |
| Rajvir Madan | M | - | 3 jaar | |
| Tood Tucker | M | - | 4 jaar | |
| Jessica Robison | F | - | 5 jaar | |
| Mika Derynck | M | 61 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
| Amanda Sheldon | F | - | 3 jaar | |
| Bruce Binkowitz | M | - | 3 jaar | |
| Charlotte Merritt | F | 61 | 7 jaar | |
| Otello Stampacchia | M | 55 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
| Don Plummer | M | - | - | |
| Meg Elias | F | 58 | 5 jaar | |
| David Berk | M | 45 | 5 jaar | |
| Maninder Hora | M | 70 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
| Patrick Burnett | M | 52 | 4 jaar | |
| Todd Edwards | M | 61 | 1 jaar | |
| Courtney Barton | F | 41 | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Joseph Turner | M | 72 | 11 jaar | |
| Scott Burrows | M | 47 | 4 jaar | |
| John Smither | M | 71 | 13 jaar | |
| Nathaniel David | M | 56 | 11 jaar | |
| F. Ball | M | 68 | 2 jaar | |
| Angie You | M | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 4 jaar |
| Daniel J. Estes | M | 43 | 3 jaar | |
| Frank Pompilio | M | 60 | 2 jaar | |
| François Kress | M | 57 | 5 jaar | |
| David W. Osborne | M | 62 | - | |
| Keith L. Klein | M | 60 | 2 jaar | |
| Ricky Sun | M | 50 | - | |
| Patricia A. Turney | F | 57 | - | |
| Alexander G. Asam | M | 58 | 1 jaar | |
| Camille Samuels | F | 52 | 10 jaar | |
| Rowe Heather Armstrong | F | - | 1 jaar | |
| Jonathan Silverstein | M | 57 | 3 jaar | |
| David Schnell | M | 64 | 8 jaar | |
| Dennis Fenton | M | 72 | 9 jaar | |
| Hollings Renton | M | 77 | 1 jaar | |
| Robert Nelsen | M | 60 | 8 jaar | |
| Kenneth Lock | M | 50 | 3 jaar | |
| Jen Herbach | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 jaar |
| Kimberly Lathroum | F | - | 3 jaar | |
| Corey Padovano | M | - | - | |
| Eric McIntyre | M | - | - | |
| Lynn Navale | F | 53 | - | |
| Ursula McCurry | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 jaar |
| Matthew Moore | M | 51 | 3 jaar | |
| Steven Pfeiffer | M | 48 | 4 jaar | |
| Alexander Azoy | M | 48 | - | |
| Susan Lundeen Smuck | F | 57 | 9 jaar | |
| Bryan Irving | M | 60 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 jaar |
| Diane Stroehmann | F | 46 | 2 jaar | |
| Majed Kheir | M | 46 | 3 jaar | |
| Elisabeth Sandoval | F | 62 | 3 jaar | |
| Susan R. Lundeen-Smuck | F | 58 | 9 jaar | |
| Charles W. Stiefel | M | - | - | |
| David Hirsch | M | 53 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 jaar |
| Douglas A. Rich | M | 55 | - | |
| Patricia Millican | F | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 jaar |
| Patricia Walker | M | 64 | 8 jaar | |
| Zaneta Odrowaz | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 73 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Todd Watanabe
- Persoonlijk netwerk